Table 3.
Diabetes |
No diabetes |
|||||||
---|---|---|---|---|---|---|---|---|
Women |
Men |
Women |
Men |
|||||
HR (95% CI) | χ2 | HR (95% CI) | χ2 | HR (95% CI) | χ2 | HR (95% CI) | χ2 | |
Mortality, all causes | ||||||||
Age, 10-year groups | 2.42 (2.07–2.82) | 125.3 | 2.20 (1.93–2.51) | 137.1 | 2.47 (2.31–2.66) | 629.6 | 2.31 (2.18–2.46) | 705.7 |
Diagnosis year, by 10 years | 1.02 (0.84–1.24) | 0.04 | 0.83 (0.68–1.01) | 3.5 | 0.71 (0.65–0.78) | 48.5 | 0.72 (0.66–0.79) | 51.5 |
CVD mortality | ||||||||
Age, 10-year groups | 2.45 (2.00–2.99) | 76.8 | 2.22 (1.87–2.63) | 84.9 | 3.08 (2.78–3.41) | 455.0 | 2.61 (2.39–2.84) | 463.9 |
Diagnosis year, by 10 years | 0.95 (0.74–1.22) | 0.2 | 0.73 (0.57–0.94) | 6.0 | 0.70 (0.62–0.80) | 26.9 | 0.69 (0.61–0.78) | 37.0 |
CHD mortality | ||||||||
Age, 10-year groups | 2.09 (1.63–2.69) | 33.5 | 2.06 (1.69–2.52) | 51.3 | 2.97 (2.58–3.41) | 230.1 | 2.43 (2.19–2.70) | 273.7 |
Diagnosis year, by 10 years | 0.79 (0.56–1.11) | 1.9 | 0.65 (0.48–0.88) | 7.6 | 0.59 (0.49–0.71) | 31.8 | 0.63 (0.54–0.73) | 38.0 |
Cerebrovascular disease mortality | ||||||||
Age, 10-year groups | 3.44 (2.17–5.46) | 27.7 | 2.70 (1.81–4.10) | 23.3 | 3.23 (2.61–3.98) | 118.4 | 3.16 (2.52–3.97) | 99.0 |
Diagnosis year, by 10 years | 1.24 (0.73–2.09) | 0.6 | 0.98 (0.53–1.78) | 0 | 0.77 (0.58–1.01) | 3.5 | 0.76 (0.56–1.03) | 3.0 |
Malignant neoplasm mortality | ||||||||
Age, 10-year groups | 1.43 (1.04–1.97) | 4.8 | 1.93 (1.43–2.60) | 18.5 | 1.61 (1.42–1.83) | 52.2 | 1.85 (1.64–2.10) | 99.3 |
Diagnosis year, by 10 years | 1.37 (0.83–2.24) | 1.5 | 1.27 (0.80–2.03) | 1.0 | 0.68 (0.56–0.83) | 14.6 | 0.72 (0.59–0.88) | 10.8 |
Mortality from all other causes | ||||||||
Age, 10-year groups | 3.59 (2.52–5.11) | 49.9 | 2.39 (1.78–3.19) | 34.3 | 2.47 (2.15–2.84) | 164.7 | 2.22 (1.96–2.52) | 154.8 |
Diagnosis year, by 10 years | 1.01 (0.67–1.53) | 0.002 | 0.84 (0.54–1.30) | 0.6 | 0.77 (0.63–0.93) | 7.5 | 0.81 (0.67–0.97) | 5.3 |
Data are HRs (95% CI) or χ2 estimate.